Elevated Lp(a) and its LPA gene are common monogenic risk factors for CAD, valvular, and vascular disorders.12, 13, 14, 15 Despite high cardiovascular risk and substantial genetic diversity among ME populations, this region remains significantly underrepresented in global Lp(a) studies. The gene discussed is LPA; the disease is coronary artery disorder.